Radioprotective Effect of Epigallocatechin-3-Gallate on Salivary Gland Dysfunction After Radioiodine Ablation in a Murine Model
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives. Radioiodine (RI) therapy is known to subject cellular components of salivary glands (SG) to oxidative stress leading to SG dysfunction. However, the protective effects of antioxidants on RI-induced SG damage have not been well investigated. The authors investigated the morphometric and functional effects of epigallocatechin-3-gallate (EGCG) administered prior to RI therapy and compared this with the effects of amifostine (a well-known antioxidant)in a murine model of RI sialadenitis. Methods. Four-week-old female C57BL/6 mice (n=48) were divided into four groups; a normal control group, a RI-treated group (0.01 mCi/g mouse, orally), an EGCG and RI-treated group, and an amifostine and RI-treated group. Animals in these groups were divided into 3 subgroups and euthanized at 15, 30, and 90 days post-RI treatment. Salivary flow rates and lag times were measured, and morphologic and histologic examinations and TUNEL (terminal deoxynucleotidyl transferase biotin-dUDP nick end labeling) assays were performed. Changes in salivary 99mTc pertechnetate uptake and excretion were followed by single-photon emission computed tomography. Results. Salivary flow rates and lag times to salivation in the EGCG or amifostine groups were better than in the RI-treated group. Histologic examinations of SGs in the EGCG or amifostine group showed more mucin-rich parenchyma and less periductal fibrosis than in the RI-treated group. Fewer apoptotic cells were observed in acini, ducts, and among endothelial cells in the EGCG or amifostine group than in the RI group. In addition, patterns of 99mTc pertechnetate excretion were quite different in the EGCG or amifostine group than in the RI group. Conclusion. EGCG supplementation before RI therapy could protect from RI-induced SG damage in a manner comparable to amifostine, and thus, offers a possible means of preventing SG damage by RI.
Abstract
Objectives. Radioiodine (RI) therapy is known to subject cellular components of salivary glands (SG) to oxidative stress leading to SG dysfunction. However, the protective effects of antioxidants on RI-induced SG damage have not been well investigated. The authors investigated the morphometric and functional effects of epigallocatechin-3-gallate (EGCG) administered prior to RI therapy and compared this with the effects of amifostine (a well-known antioxidant)in a murine model of RI sialadenitis. Methods. Four-week-old female C57BL/6 mice (n=48) were divided into four groups; a normal control group, a RI-treated group (0.01 mCi/g mouse, orally), an EGCG and RI-treated group, and an amifostine and RI-treated group. Animals in these groups were divided into 3 subgroups and euthanized at 15, 30, and 90 days post-RI treatment. Salivary flow rates and lag times were measured, and morphologic and histologic examinations and TUNEL (terminal deoxynucleotidyl transferase biotin-dUDP nick end labeling) assays were performed. Changes in salivary 99mTc pertechnetate uptake and excretion were followed by single-photon emission computed tomography. Results. Salivary flow rates and lag times to salivation in the EGCG or amifostine groups were better than in the RI-treated group. Histologic examinations of SGs in the EGCG or amifostine group showed more mucin-rich parenchyma and less periductal fibrosis than in the RI-treated group. Fewer apoptotic cells were observed in acini, ducts, and among endothelial cells in the EGCG or amifostine group than in the RI group. In addition, patterns of 99mTc pertechnetate excretion were quite different in the EGCG or amifostine group than in the RI group. Conclusion. EGCG supplementation before RI therapy could protect from RI-induced SG damage in a manner comparable to amifostine, and thus, offers a possible means of preventing SG damage by RI.
참고문헌 (30)
- Mandel SJ., "Radioactive iodine and the salivary glands", Thyroid, 13(3), pp.265~271 (2003)
- Weiss JF., "History and development of radiation-protective agents", Int J Radiat Biol, 85(7), pp.539~573 (2009)
- Okumura H., "Effects of amifostine administration prior to irradiation to the submandibular gland in mice : autoradiographic study using 3H-leucine", Okajimas Folia Anat Jpn, 85(4), pp.151~160 (2009)
- Joseph LJ., "Radioprotective effect of Ocimum sanctum and amifostine on the salivary gland of rats after therapeutic radioiodine exposure", Cancer Biother Radiopharm, 26(6), pp.737~743 (2011)
- Ma C., "Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer", Eur J Nucl Med Mol Imaging, 37(9), pp.1778~1785 (2010)
- Ma C., "Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer", Cochrane Database Syst Rev, (4), pp.CD007956~ (2009)
- Katiyar SK, "Skin photoprotection by green tea : antioxidant and immunomodulatory effects", Curr Drug Targets Immune Endocr Metabol Disord, 3(3), pp.234~242 (2003)
- Afaq F., "Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent(-)-epigallocatechin-3-gallate", Oncogene, 22(7), pp.1035~1044 (2003)
- Katiyar SK., "Green tea polyphenol(-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress", Carcinogenesis, 22(2), pp.287~294 (2001)
- Mukhtar H., "Tea polyphenols: prevention of cancer and optimizing health", Am J Clin Nutr, 71(6 Suppl), pp.1698S~1702S (2000)
- Sueoka N., "A new function of green tea : prevention of lifestyle-related diseases", Ann N Y Acad Sci, 928, pp.274~280 (2001)
- Hsu S., "Inhibition of autoantigen expression by(-)-epigallocatechin-3-gallate(the major constituent of green tea)in normal human cells", J Pharmacol Exp Ther, 315(2), pp.805~811 (2005)
- Vanhove C., "Interest of the ordered subsets expectation maximization(OS-EM)algorithm in pinhole single-photon emission tomography reconstruction : a phantom study", Eur J Nucl Med, 27(2), pp.140~146 (2000)
- Defrise M., "Perturbative refinement of the geometric calibration in pinhole SPECT", IEEE Trans Med Imaging, 27(2), pp.204~214 (2008)
- La Vecchia C., "Thyroid cancer mortality and incidence : a global overview", Int J Cancer, 136(9), pp.2187~2195 (2015)
- Levy O., "The Na+", I-symporter(NIS) : recent advances, 1998, pp.30(2), 195~206
- Van Nostrand D, "Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer", Oral Dis, 17(2), pp.154~161 (2011)
- La Perle KM., "Modulation of sodium", iodide symporter expression in the salivary gland, 2013, pp.23(8), 1029~1036
- Dorr RT., "Radioprotectants: pharmacology and clinical applications of amifostine", Semin Radiat Oncol, 8(4 Suppl 1), pp.10~13 (1998)
- Hensley ML., "American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants", J Clin Oncol, 17(10), pp.3333~3355 (1999)
- Jensen SB., "A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies : management strategies and economic impact", Support Care Cancer, 18(8), pp.1061~1079 (2010)
- Hosseinimehr SJ, "Trends in the development of radioprotective agents", Drug Discov Today, 12(19-20), pp.794~805 (2007)
- Kim SJ., "Limited cytoprotective effects of amifostine in high-dose radioactive iodine 131-treated well-differentiated thyroid cancer patients : analysis of quantitative salivary scan", Thyroid, 18(3), pp.325~331 (2008)
- Noaparast Z., "Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy", Future Oncol, 9(8), pp.1145~1159 (2013)
- Dickinson D., "Epigallocatechin-3-gallate modulates anti-oxidant defense enzyme expression in murine submandibular and pancreatic exocrine gland cells and human HSG cells", Autoimmunity, 47(3), pp.177~184 (2014)
- Saito K., "Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Fas(lpr)mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2", Autoimmunity, 47(1), pp.13~22 (2014)
- Kutta H., "Amifostine is a potent radioprotector of salivary glands in radioiodine therapy. Structural and ultrastructural findings", Strahlenther Onkol, 181(4), pp.237~245 (2005)
- Choi JS., "Morphometric and functional changes of salivary gland dysfunction after radioactive iodine ablation in a murine model", Thyroid, 23(11), pp.1445~1451 (2013)
- Choi JS., "Analysis of age-related changes in the functional morphologies of salivary glands in mice", Arch Oral Biol, 58(11), pp.1635~1642 (2013)
- Yamamoto T., "Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells", J Pharmacol Exp Ther, 307(1), pp.230~236 (2003)